---All---
  • ---All---
  • Accession
  • Catalog #

IGFBP4 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP6941c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP6941c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

IGFBP4 Antibody (Center) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP22692
Other AccessionNP_001543.2
ReactivityHuman, Mouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW27934 Da

IGFBP4 Antibody (Center) - Additional info

Gene ID 3487
Other Names
IGFBP4; IBP4; Insulin-like growth factor-binding protein 4
Target/Specificity
This IGFBP4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 103-132 amino acids from the Central region of human IGFBP4.
Dilution
WB~~1:100~500
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
IGFBP4 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

IGFBP4 Antibody (Center) - Protein Information

Name IGFBP4
Synonyms IBP4
Function
IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors
Cellular Location
Secreted.

IGFBP4 Antibody (Center) - Related products

AP6941a: IGFBP4 Antibody (N-term)

AP6941c: IGFBP4 Antibody (Center)

RI12663: IGFBP4 predesign siRNA

BP6941a: IGFBP4 Antibody (N-term) Blocking Peptide

BP6941c: IGFBP4 Antibody (Center) Blocking peptide

AF1558a: IGFBP4 Antibody

IGFBP4 Antibody (Center) - Application data

  • IGFBP4 Antibody (Center) (Cat. #AP6941c) western blot analysis in mouse lung tissue lysates (15ug/lane).This demonstrates the IGFBP4 antibody detected IGFBP4 protein (arrow).

  • IGFBP4 antibody (Center) (Cat. #AP6941c) immunohistochemistry analysis in formalin fixed and paraffin embedded human placenta tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the IGFBP4 antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.

IGFBP4 Antibody (Center) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.

REFERENCES

Giroux, S., et al. Bone 47(5):975-981(2010) Canzian, F., et al. Hum. Mol. Genet. 19(19):3873-3884(2010) Bartling, B., et al. Int. J. Mol. Med. 25(1):89-96(2010) Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) : Yerges, L.M., et al. J. Bone Miner. Res. 24(12):2039-2049(2009)